Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Price Target Cut to $136.00

Cornelia Mascio
Novembre 15, 2017

Jefferies Group LLC reissued their buy rating on shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) in a report released on Friday, November 3rd. Zimmer Biomet Holdings now has an average rating of "Hold" and an average price target of $133.71. SunTrust Banks Inc. began coverage on shares of Zimmer Biomet Holdings in a report on Thursday, August 11th. The company has a market capitalization of $22,423.90, a PE ratio of 13.72, a price-to-earnings-growth ratio of 1.72 and a beta of 1.17. Canaccord Genuity reiterated a buy rating and issued a $141.00 price objective on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. BidaskClub downgraded Zimmer Biomet Holdings from a "buy" rating to a "hold" rating in a report on Monday, July 24th. Needham maintained Zimmer Biomet Holdings Inc (NYSE:ZBH) on Wednesday, July 12 with "Buy" rating. (NYSE:ZBH) had its price target cut by research analysts at Morgan Stanley from $146.00 to $136.00 in a research report issued to clients and investors on Thursday, November 2nd. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company. Harbour Capital Advisors LLC grew its holdings in Zimmer Biomet Holdings by 13,131.3% in the 2nd quarter. The stock has a 50 day moving average of $124.67 and a 200-day moving average of $123.11. The company has market cap of $22.72 billion. Zimmer Biomet Holdings has a one year low of $95.63 and a one year high of $133.49. The stock of Zimmer Biomet Holdings Inc (NYSE:ZBH) has "Outperform" rating given on Monday, November 2 by RBC Capital Markets. The company reported $1.79 earnings per share for the quarter, meeting analysts' consensus estimates of $1.79. Zimmer Biomet Holdings had a net margin of 3.46% and a return on equity of 16.48%. The company had revenue of $1.82 billion for the quarter, compared to analyst estimates of $1.83 billion. During the same period in the prior year, the business earned $1.79 earnings per share. They expect $0.50 EPS, up 47.06% or $0.16 from last year's $0.34 per share. Zimmer Biomet Holdings's dividend payout ratio is 75.00%.

More notable recent Zimmer Biomet Holdings Inc (NYSE:ZBH) news were published by: Investorplace.com which released: "Zimmer Biomet Holdings, Inc.'s (ZBH) Upgraded to Hold" on November 07, 2017, also Nasdaq.com with their article: "Zimmer Biomet Holdings is Now Oversold (ZBH)" published on November 03, 2017, Nasdaq.com published: "Zimmer Biomet Holdings Inc". The shares were sold at an average price of $129.96, for a total transaction of $352,971.36. Following the transaction, the insider now owns 2,000 shares of the company's stock, valued at approximately $259,920. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Zimmer Biomet Holdings presently has an average rating of Hold and an average price target of $133.71. Palo Alto Investors Llc owns 1.95 million shares or 13.05% of their United States portfolio. The disclosure for this sale can be found here. Insiders own 1.22% of the company's stock. The stock of Zimmer Biomet Holdings Inc (NYSE:ZBH) has "Buy" rating given on Thursday, July 27 by Piper Jaffray. Winslow Capital Management LLC purchased a new position in Zimmer Biomet Holdings during the second quarter valued at $310,013,000. Caxton Associates LP bought a new position in shares of Zimmer Biomet Holdings in the first quarter valued at about $403,000. Koch Industries Inc. now owns 1,040,764 shares of the medical equipment provider's stock valued at $1,033,000 after buying an additional 1,038,674 shares during the period. Massachusetts Financial Services Co. MA raised its position in Zimmer Biomet Holdings by 8.5% in the second quarter. Andra AP fonden now owns 21,300 shares of the medical equipment provider's stock worth $2,735,000 after purchasing an additional 2,900 shares in the last quarter. Finally, Andra AP fonden raised its holdings in shares of Zimmer Biomet Holdings by 15.8% in the second quarter. Jensen Investment Management Inc. now owns 5,850 shares of the medical equipment provider's stock worth $751,000 after purchasing an additional 1,140 shares in the last quarter.

Zimmer Biomet Holdings, Inc.is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Altre relazioniGrafFiotech

Discuti questo articolo

PIÙ POPOLARE GrafFiotech

Segui i nostri GIORNALE